Blood testing method, testing chip, and testing device

摘要

The present invention provides a blood testing method capable of accurately and easily performing quantitative analysis of the progression of tumors and the therapeutic reactivity, without placing any heavy burden on a patient, by detecting a mutation factor derived from tumor cells and a normal factor with no mutation in a sample containing human plasma with the mutation factor, and by calculating a relative ratio between the mutation factor amount and the normal factor amount.